Sort   by:  
 Page size 
UnknownStructural insights into BCL2 pro-survival protein interactions with the key autophagy regulator BECN1 following phosphorylation by STK4/MST1.
Not available
S-EPMC6526822 | biostudies-literature
UnknownBcl-2, Bcl-x(L), and Bcl-w are not equivalent targets of ABT-737 and navitoclax (ABT-263) in lymphoid and leukemic cells.
Not available
S-EPMC3382939 | biostudies-literature
ProteomicsVDAC2 ligands selectively and potently block BAK-mediated apoptosis to allow long-term clonogenic cell survival
This study aimed to characterise the protein that a novel compound binds to, thus promoting its ability to inhibit BAK apoptotic activity.
ORGANISM(S): Homo sapiens (Human) 
2019-10-11 | PXD013129 | Pride
Compound target id 
UnknownComputationally designed high specificity inhibitors delineate the roles of BCL2 family proteins in cancer.
Not available
S-EPMC5127641 | biostudies-literature
UnknownBCL-XL inhibitors enhance the apoptotic efficacy of BRAF inhibitors in BRAFV600E colorectal cancer.
Not available
S-EPMC10907349 | biostudies-literature
UnknownComputational design of potent and selective binders of BAK and BAX.
Not available
S-EPMC12412652 | biostudies-literature
UnknownBCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival.
Not available
S-EPMC6482196 | biostudies-literature
UnknownAntibodies specifically targeting a locally misfolded region of tumor associated EGFR.
Not available
S-EPMC2656555 | biostudies-literature
UnknownGuidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Not available
S-EPMC4835977 | biostudies-literature
Sort   by:  
 Page size